Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
05 February 2021 - 8:02AM
Fluidigm Corporation (Nasdaq:FLDM), an innovative
biotechnology tools provider with a vision to improve life through
comprehensive health insight, today announced that the company’s
management will participate in investor meetings at the BTIG
Virtual MedTech, Digital Health, Life Science and Diagnostic Tools
Conference on Thursday, February 18, 2021.
Chris Linthwaite, President and CEO, will participate in a
virtual fireside chat and present updates regarding Fluidigm’s
business strategy and financial performance at 2:00 pm ET. A live
webcast and subsequent replay will be available in the Events &
Presentations section of the Fluidigm investor website. The replay
will be available two hours after the live session and will be
archived for the following 90 days.
About FluidigmFluidigm (Nasdaq:FLDM)
focuses on the most pressing needs in translational and clinical
research, including cancer, immunology, and immunotherapy. Using
proprietary CyTOF® and microfluidics technologies, we develop,
manufacture, and market multi-omic solutions to drive meaningful
insights in health and disease, identify biomarkers to inform
decisions, and accelerate the development of more effective
therapies. Our customers are leading academic, government,
pharmaceutical, biotechnology, plant and animal research, and
clinical laboratories worldwide. Together with them, we strive to
increase the quality of life for all. For more information,
visit fluidigm.com.
Fluidigm, the Fluidigm logo, Advanta and
CyTOF are trademarks and/or registered trademarks of Fluidigm
Corporation in the United States and/or other
countries. All other trademarks are the sole property of their
respective owners. The Advanta™ Dx SARS-CoV-2 RT-PCR Assay is
for In Vitro Diagnostic Use. It is for Use under
Emergency Use Authorization Only. Rx Only.
Other Fluidigm products are provided for Research Use
Only. Not for use in diagnostic procedures.
Available Information We use our website
(fluidigm.com), investor site (investors.fluidigm.com), corporate
Twitter account (@fluidigm), Facebook page (facebook.com/Fluidigm),
and LinkedIn page (linkedin.com/company/fluidigm-corporation) as
channels of distribution of information about our products, our
planned financial and other announcements, our attendance at
upcoming investor and industry conferences, and other matters. Such
information may be deemed material information, and we may use
these channels to comply with our disclosure obligations under
Regulation FD. Therefore, investors should monitor our website and
our social media accounts in addition to following our press
releases, SEC filings, public conference calls, and
webcasts.
Contact:
Agnes LeeVice President, Investor RelationsFluidigm
Corporation650 416 7423agnes.lee@fluidigm.com
Fluidigm (NASDAQ:FLDM)
Historical Stock Chart
From Apr 2024 to May 2024
Fluidigm (NASDAQ:FLDM)
Historical Stock Chart
From May 2023 to May 2024